Sfoglia per AUTORE
FALLACARA A
Collezione ASL Asti

  

Items : 3

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study in Journal of the Neurological Sciences

2021
ASL Asti

Salerno A; Torelli P; Albanese M; Egeo G; Fofi L; Messina R; Aurilia C; Cevoli S; Barbanti P; Trimboli M; Pascarella A; Manzo L; Bertuzzo D; Zucco M; Di Clemente L; Costa CM; Brunelli N; Fallacara A; Favoni V; Finocchi C; Di Fiore P; D'Onofrio F; Grazzi L; Aguggia M; Colombo B; Frediani F; Mercuri B; D'Amico D; Filippi M; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in real-life in Journal of the Neurological Sciences

2021
ASL Asti

Pascarella A; Manzo L; Barbanti P; Zucco M; Di Clemente L; Trimboli M; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Favoni V; Finocchi C; Fiore PD; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Vernieri F; Colombo B; Frediani F; Bono F; D'Amico D; Filippi M; Altamura C; Torelli P; Albanese M; Carnevale A; Fofi L; Cevoli S; et alii...

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Dec;41(Suppl 2):487-488. doi: 10.1007/s10072-020-04669-y.

2020
ASL Asti
ASL Vercelli

Cevoli S; Barbanti P; Albanese M; Frediani F; Di Fiore P; Bertuzzo D; Aguggia M; Fallacara A; Favoni V; Pierangeli G; Costa CM; Fofi L; Brunelli N; Vernieri F; Egeo G; Aurilia C; Altamura C;